NIFTY 50▲24,834.85
428.75 (1.76%)
SENSEX▲81,332.72
1292.92 (1.62%)
NIFTY BANK▲51,295.95
407.20 (0.80%)
INDIAN RAILWAY FINANCE CORP▼183.44
-0.12 (-0.07%)
TATA MOTORS▲1,118.30
27.35 (2.51%)
TATA STEEL▲162.55
5.16 (3.28%)
TATA POWER▲444.70
21.35 (5.04%)
SUZLON ENERGY▲61.89
0.42 (0.68%)
RAIL VIKAS NIGAM▼552.35
-23.35 (-4.06%)
INDIAN RENEWABLE ENERGY▼258.03
-3.15 (-1.21%)
VODAFONE IDEA▲15.98
0.80 (5.27%)
RELIANCE INDUSTRIES▲3,018.05
33.25 (1.11%)
YES BANK▲24.97
0.35 (1.42%)
ADANI POWER▲712.65
17.45 (2.51%)
NHPC▲104.62
2.66 (2.61%)
STATE BANK OF INDIA▲862.45
13.95 (1.64%)
HDFC BANK▲1,618.15
1.55 (0.10%)
RELIANCE POWER▲29.77
0.08 (0.27%)
JIO FIN SERVICES LTD▲331.90
2.70 (0.82%)
ZOMATO▲224.62
5.31 (2.42%)
ADANI PORT & SEZ▲1,542.75
55.75 (3.75%)
BHARAT ELECTRONICS▲309.90
8.45 (2.80%)
INDIAN RAILWAY TOURISM CORP▲984.15
15.00 (1.55%)
INDIAN OIL CORP▼176.55
-0.30 (-0.17%)
RATTANINDIA POWER▲16.87
0.06 (0.36%)
MRF▲1,38,870.35
1280.25 (0.93%)
ADANI ENTERPRISES▲3,080.50
107.00 (3.60%)
JAIPRAKASH POWER VENTURES▲19.66
0.83 (4.41%)
![stock logo](https://assets.upstox.com/content/assets/images/logos/NSE_EQ|INE03Q201024.png)
Glenmark Life Science Share Price
GLS
₹850.70-₹25.55 (-2.92%) TodayLast updated on 26 Jul, 2024 | 15:42 IST
₹847.30₹905.00
L
H
What’s in news?
Company overview
Financial performance
Market cap
| Open₹873.50 | Close₹876.25 |
Circuit range₹963.85 - ₹788.65 | Day range₹847.30 - ₹905.00 | Year range₹596.00 - ₹972.00 |
Volume3,71,753 | Avg. traded₹863.90 | Revenue (12m)₹2,283 Crs |
Glenmark Life ScienceGlenmark Life Sciences Limited is an India-based developer and manufacturer of non-commoditized, active pharmaceutical ingredients (APIs) in chronic therapeutic areas. The Company is providing contract development and manufacturing (CDMO) services to a range of multinational and specialty pharmaceutical companies. Its primary therapy areas include cardiovascular (CVS) disease, central nervous system (CNS) disorders, diabetes, oncology, pain management (anti-migraine, analgesic) and anti-infectives (antibiotic). It also develops APIs in the therapeutic areas such as anti-fungal, anti-histaminic, anti-acne, anti-emetic, ophthalmologic agent, urinary and anti-spasmodic. It has a diversified portfolio of around 151 molecules & supplies its products to customers in India, Europe, North America, Latin America, Japan and the rest of the world. Its four manufacturing facilities are located in Ankleshwar, Dahej, Mohol and Kurkumbh with a total installed capacity of approximately 1198 KL.
Glenmark Life Science Key indicators
52 week high₹972.00 | 52 week low₹596.00 | P/E ratio22.22 |
P/B ratio4.6 | ROE22.33% | ROCE30.01% |
Dividend yield2.57% | Debt/Equity ratio | EPS38.11 |
Learn more
Featured in
Investment checklist: (5/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Analyst ratings:
Analyst ratings:
75%
Hold
25%
Sell
0%
This analysis is based on the reviews of 4 experts in the last 7 days
Fundamentals
Financial ratios
Operating profit margin30.89% | Net profit margin21.49% |
ROE22.33% | ROA15.43% |
ROCE30.01% |
Learn more
Glenmark Life Science Share Price history
Day | Open | Close | Day’s change |
---|---|---|---|
Thu, Jul 25 2024 | ₹858.80 | ₹876.25 | |
Wed, Jul 24 2024 | ₹857.00 | ₹853.80 | |
Tue, Jul 23 2024 | ₹846.50 | ₹852.85 | |
Mon, Jul 22 2024 | ₹841.50 | ₹850.40 | |
Fri, Jul 19 2024 | ₹851.35 | ₹847.35 | -0.47% |
Thu, Jul 18 2024 | ₹855.00 | ₹851.35 | -0.44% |
Tue, Jul 16 2024 | ₹847.95 | ₹855.10 | |
Mon, Jul 15 2024 | ₹843.40 | ₹845.25 | -0.36% |
Events
Corporate actions
Dividend • ₹22.5/share
Ex date 17 Oct 2023
Dividend • ₹21/share
Ex date 24 Mar 2023
Dividend • ₹10.5/share
Ex date 15 Sep 2022
Dividend • ₹10.5/share
Ex date 22 Nov 2021
Learn more